Monoplace Delivery System
Monthly Hyperbaric Safety Notice: February 2006
Cleaning and Decontamination of Tissue Oxygen Sensors
Introduction
Transcutaneous oxygen screening is an important element of the case management of patients with wound healing deficiencies. As the sensor electrode and the cable may come into direct contact with the patient, a cleansing procedure must be in place to minimize the risk of cross-contamination.
The Issue
Without adequate cleansing of the sensor electrode and cable, cross-contamination is a distinct possibility. An increasing number of patients are diagnosed with serious infectious diseases such as VRE, MRSA, HIV, etc., many others are infected but not presently diagnosed. Appropriate precautions and barriers are routinely required in today’s health care climate. This Notice will ensure that such precautions are extended to transcutaneous technology and patient testing.
Upon completion of every transcutaneous study, and prior to any further patient testing, the sensor and cable should be cleansed, as follows:
Spray the back of the sensor electrode head and the cable with Tor-HB (Huntington ®). Be careful not to allow any of this solution to come into contact with the electrode plug, and avoid Tor-HB contact with the membrane. Let sit for 10 minutes. Spray or rinse with sterile water for approximately 60 seconds or until all of the Tor-HB has been removed.
Prior to re-membraning the sensor electrode, following the testing of patients with significant infective states (examples include VRE, MRSA, HIV), or if the electrode comes into direct contact with a wound.
Remove the sensor electrode membrane. Immerse the electrode and cable, but not the cable plug, into dilute Tor-HB. Let sit for 10 minutes. Spray or rise with sterile water for approximately 60 seconds or until all Tor-HB has been removed. Dry off the sensor electrode with blotting paper and re-membrane.
Never heat sterilize the sensor membrane and cable.
Bottom Line
In order to minimize the risk of cross-contamination during transcutaneous oxygen testing, the cleansing policies established within this Safety Notice will be adhered to.
Contributing Author: Dick Clarke, CHT
Dick
is President of National Baromedical Services, which he founded in 1986. His
previous background included service in the British Royal Navy, diving instructor
and underwater photographer, assistant director of the seabed habitat 'HydroLab'
and several years in the offshore commercial diving industry. Dick heads the
Baromedical Research Foundation where he serves as Principal Investigator for
several international clinical trials. He is course director for 'Primary Training
in Hyperbaric Medicine' and the 'HBO 2000' series of advanced hyperbaric symposia.
Dick has been a NOAA Diving Medical Officer Training Course faculty member since
1983. He pioneered the Certification in Hyperbaric Technology (CHT) program,
is a past president of the National Board of Diving and Hyperbaric Medical Technology
and remains active at the committee level within the Undersea and Hyperbaric
Medical Society.
Full Panel of Safety and Technical Correspondents
Previous Monoplace Safety Notices:
- January 2006
- December 2005
- November 2005
- October 2005
- September 2005
- August 2005
- July 2005
- June 2005

